Advertisement

Topics

Addressing Antimicrobial Resistance and Stewardship

20:00 EDT 2 Aug 2017 | JAMA

This Viewpoint describes the Priority Antimicrobial Value and Entry (PAVE) award, which has been proposed to address the problem of antimicrobial-resistant infections using limited public funds to shift to value-based payment for new, high-priority antimicrobial drugs.

Original Article: Addressing Antimicrobial Resistance and Stewardship

NEXT ARTICLE

More From BioPortfolio on "Addressing Antimicrobial Resistance and Stewardship"

Quick Search
Advertisement